Patient info Open main menu

Psoriderm Scalp Lotion Shampoo – Summary of Product Characteristics (SmPC) for healthcare professionals

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Pharmacy medicine (P) Details

Medicine strength:
25 mg/ml
Other strengths and forms:
Contains active substance:

Summary of Product Characteristics (SmPC) - Psoriderm Scalp lotion shampoo

1 NAME OF THE MEDICINAL PRODUCT

Psoriderm Scalp Lotion Shampoo

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Distilled coal tar 2.5% w/v

For the full list of excipients, see section 6.1.

3. PHARMACEUTICAL FORM

Golden brown coloured foaming therapeutic SHAMPOO

4. CLINICAL PARTICULARS

4.1. Therapeutic indications

For the topical treatment of psoriasis of the scalp.

4.2 Posology and method of administration

For adults, children and the elderly.

Use as a shampoo, daily if necessary, reducing the frequency of use to once or twice a week as the condition improves. Thereafter, occasional use may be necessary.

Wet the hair thoroughly. Apply a small amount of the shampoo to the scalp (approximately a quantity the size of a fifty pence piece for short hair, adjusting up depending on length/thickness of hair), and massage gently until a rich lather has been generated. Retain on the scalp for a few minutes. Remove excess lather with the hands before rinsing with warm water. If necessary, repeat the above procedure.

4.3 Contraindications

Not to be used for acute, sore or pustular psoriasis or in the presence of infection. Not to be used in cases of hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

4.4 Special warnings and precautions for use

Keep away from the eyes and mucous membranes.

Replace cap after use.

Avoid spillage.

If there is no improvement after 4 weeks, or the scalp condition seems to look or feel worse, discontinue treatment and tell your doctor, pharmacist or nurse.

4.5. Interactions with other medicinal products and other forms of interaction

None known

4.6 Fertility, pregnancy and lactation

No special precautions.

4.7. Effects on ability to drive and use machines

None known.

4.8 Undesirable effects

Local side-effects do not normally occur. In rare cases of skin irritation, acne-like eruptions or photosensitivity, discontinue treatment. Rarely, Psoriderm Scalp Lotion may stain skin, hair or fabric.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9 Overdose

There are no known toxic effects resulting from excessive use of Psoriderm Scalp Lotion.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Antipsoriatics for topical use, Tars. ATC code: D05AA.

Coal tar has been used dermatologically for hundreds of years and has been shown to be safe and effective in the treatment of scaly scalp conditions such as psoriasis. The British Pharmacopoeia contains monographs on coal tar and coal tar solution, and many formulations of coal tar are used in hospitals throughout the country. The coal tar used in Psoriderm Scalp Lotion Shampoo has been specially distilled and is based on a neutral fraction which has been shown to be effective in the treatment of psoriasis.

The precise mechanism of action of coal tar is not understood, largely as a result of it comprising up to 10 000 components. There is evidence that topical application of coal tar improves psoriasis by reducing the excessive rate of mitotic epidermal cell division.

Lecithin is added to Psoriderm Scalp Lotion Shampoo to soften psoriasis scales and thereby enhance the absorption of the coal tar.

5.2. Pharmacokinetic properties

Not applicable.

5.3. Preclinical safety data

Not applicable.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Lecithin

Triethanolamine lauryl sulfate (trolamine lauril sulfate) (contains methylchloroisothiazolinone /methylisothiazolinone (3:1) as a preservative)

Lauric acid diethanolamide

Disodium edetate

Sodium chloride

Phenoxyethanol

Ammonium sulfate

Water purified

6.2 Incompatibilities

Not applicable.

6.3. Shelf life

36 months in unopened container

6.4. Special precautions for storage

Do not store above 25ºC.

6.5 Nature and contents of container

250 ml white, high density polyethylene BOTTLE incorporating a low density polyethylene plug. Polypropylene SCREW CAP with internal spigot seal.

6.6. Instruction for use, handling and disposal

Not applicable

7 MARKETING AUTHORISATION HOLDER

Diomed Developments Limited

T/A Dermal Laboratories

Tatmore Place

Gosmore

Hitchin

Herts

SG4 7QR

UK

8. MARKETING AUTHORISATION NUMBER

PL 00173/5001R

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

04/01/2007

10 DATE OF REVISION OF THE TEXT

23/12/2024

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00173/5001

Last revision stated in the text: 23 December 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Psoriderm Scalp lotion shampoo

Prescription needed? No, but it is sold only in pharmacies (P)
Active substance Coal tar
Strength 25 mg/ml
Pharmaceutical form Shampoo
How is it taken Cutaneous
Excipients Lecithin, Triethanolamine lauryl sulfate (trolamine lauril sulfate) (contains methylchloroisothiazolinone /methylisothiazolinone (3:1) as a preservative), Lauric acid diethanolamide, Disodium edetate, Sodium chloride, Phenoxyethanol, Ammonium sulfate, Water purified
Pack sizes 250 ml
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC) Antipsoriatics for topical use, Tars
  1. D Dermatologicals
    1. D05 Antipsoriatics
      1. D05A Antipsoriatics for topical use
        1. D05AA Tars, topical antipsoriatics
Marketing authorisation PL 00173/5001 (first authorised 4 January 2007)
Marketing authorisation holder Diomed Developments Limited
Codes GTIN 5016379304019 · BNF 13090000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.